by ODWAdmin | Sep 8, 2025
Combining Metabolomics, Proteomics and Transcriptomics to Reveal Key Pathways and Biomarkers Explore how reduced KRAS activity reshapes gene expression and pathway activity in HCT-116 cells. In this application note, Panome Bio combines next-generation metabolomics,...
by Jason Heaviland | Sep 8, 2025 | Uncategorized
Why Accurate SDMA and ADMA Measurement Is Essential for PRMT5 Inhibitors The protein arginine methyltransferase (PRMT) field has a measurement problem that’s quietly undermining drug development programs across the industry. While symmetric dimethylarginine...
by ODWAdmin | Sep 6, 2025
Metabolic Profiling of Tumor and Normal Adjacent FFPE Tissue Panome Bio is excited to announce a new, fully validated service that brings comprehensive, untargeted metabolomics to formalin-fixed paraffin-embedded (FFPE) samples, TissueBridge Metabolomics. Expanding...
by ODWAdmin | Sep 5, 2025
Dive into the power of TissueBridge from Panome Bio in this sample data report. See how Panome Bio used TissueBridge – a novel Next-Generation Metabolomics workflow to analyze tumor and normal adjacent tissue from FFPE samples.
by ODWAdmin | Aug 21, 2025
Comprehensive Metabolite Profiling of FFPE Tissue Samples This poster presentation includes an in-house study directly comparing FFPE tissue with fresh frozen samples using our Next-Generation Metabolomics platform. The results of the study indicate metabolic...
